Agranulocytosis associated with enalapril

A. Elis, M. Lishner, R. Lang, M. Ravid*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


An 83-year-old patient developed agranulocytosis following six months of enalapril 10 mg/d. The patient also had received verapamil for three years. Upon discontinuation of both drugs the white blood cell count was rapidly restored. Cases of agranulocytosis due to angiotensin-converting enzyme inhibitors, mainly captopril, have been previously described. We could, however, find no single case associated with verapamil. This, and the very long exposure of the patient to verapamil, support the assumption that this life-threatening complication might have been caused by enalapril.

Original languageEnglish
Pages (from-to)461-462
Number of pages2
JournalDICP, Annals of Pharmacotherapy
Issue number5
StatePublished - 1991
Externally publishedYes


Dive into the research topics of 'Agranulocytosis associated with enalapril'. Together they form a unique fingerprint.

Cite this